Publications found:
55,899
Sort by:
2014 Analysis of the European Immunoprotein Diagnostic Testing Market: Hospital, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
This new 273-page report from Venture Planning Group provides analysis of the European immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...
November 2013
273 pages
2014 Analysis of the US Respiratory Disease Testing Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
US$ 3,680.00
... , sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, ...
November 2013
282 pages
2014 Analysis of the European Respiratory Disease Testing Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
US$ 6,640.00
... 335-page report from Venture Planning Group provides analysis of the European respiratory disease testing market, including emerging tests, technologies ... , market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market ...
November 2013
335 pages
2014 Analysis of the US Enteric Disease Testing Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus,Rotavirus, Salmonella, Shigella, Vibrio, Yersinia
US$ 4,320.00
... , sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Enteric Disease market in the US. Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, ...
November 2013
314 pages
2014 Analysis of the European Enteric Disease Testing Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia
US$ 7,520.00
... 363-page report from Venture Planning Group provides analysis of the European enteric disease testing market, including emerging tests, technologies, ... . About this Report This report presents detailed analysis of the Enteric Disease market in Europe (France, Germany, Italy, Spain, UK). Current scientific ...
November 2013
363 pages
2014 Analysis of the European Sexually-Transmitted Disease Testing Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis
US$ 6,320.00
... 318-page report from Venture Planning Group provides analysis of the European sexually-transmitted disease testing market, including emerging tests, ... profiles of leading suppliers. The report presents detailed analysis of the STD market in Europe (France, Germany, Italy, Spain, UK), Current scientific views ...
November 2013
318 pages
2014 Analysis of the Global Therapeutic Drug Monitoring (TDM) Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... volumes, sales forecasts, supplier shares) $5,500. This new 313-page report from Venture Planning Group contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and ...
November 2013
313 pages
2014 Analysis of the European Therapeutic Drug Monitoring (TDM) Market : Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
This new 291-page report from Venture Planning Group provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and ...
November 2013
291 pages
Analysis of the Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... Venture Planning Group contains 83 tables and provides analysis of the global tumor markers and special chemistry testing market, including emerging ... , such as specimen preparation devices, controls, calibrators and others. “2013 Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany ...
November 2013
320 pages
2014 Analysis of the Global Clinical Chemistry and Immunodiagnostic Market: France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 26,800.00
... Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of clinical chemistry and immunodiagnostic products by country and individual product ...
October 2013
1115 pages
2014 Analysis of the European Clinical Chemistry and Immunodiagnostic Market: France, Germany, Italy, Spain, UK, Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 15,760.00
... forecasts, supplier shares) $12,800. This comprehensive five-country report contains 900 pages and 335 tables. The report explores future trends in the European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and ...
October 2013
900 pages
2014 Analysis of the Global Transfusion Diagnostics Market: France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 26,000.00
... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Commercial/Private Laboratories Military Blood Banks Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...
October 2013
800 pages
2014 Analysis of the European Transfusion Diagnostics Market: France, Germany, Italy, Spain, UK Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 15,760.00
... and potential market entrants identify and evaluate emerging opportunities in the European transfusion diagnostic market during the next five years, and assist ... B19 NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ...
October 2013
600 pages
2014 Opportunities in the Global Clinical Chemistry and Immunodiagnostics Markets
US$ 26,800.00
Complete report $33,500. DataPack (test volumes, sales forecasts, supplier shares) $21,800. “2014 Opportunities in the Global Clinical Chemistry and Immunodiagnostics Markets” is a new seven-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic ...
September 2013
1115 pages
